Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
H2O4S/c2*1-18(2
Flumatinib is currently in Phase I and II clinical trials in China for the treatment of chronic myelogenous leukemia (CML)
Tideglusib
Src and Blk
EHT 5372 Catalog No.:M16773-C H2O4S/c2*1-18(2EHT 5372 is a highly potent and selective inhibitor of DYRKs family kinases with IC50s of 0. 22, 0. 28, 10. 8, 93. 2, 22. 8, 88. 8, 59. 0, 7. 44, 221 nM for DYRK1A, DYRK1B , DYRK2 DYRK3 CLK1, CLK2, CLK4, GSK 3, GSK 3. Product information CAS Number: 1425945 63 6 Molecular Weight: 404. 27 Formula: C17H11Cl2N5OS Chemical Name: methyl 9 [(2,4 dichlorophenyl)amino] [1,3]thiazolo[5,4 f]quinazoline 2 carboximidate Smiles:
US$ 163.95
US$ 40.00
US$ 34.91
US$ 1179.46
US$ 116.38
US$ 50.00
US$ 23.95
US$ 69.83
US$ 106.20